Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
- Market Cap ₹ 21,390 Cr.
- Current Price ₹ 1,088
- High / Low ₹ 1,150 / 435
- Stock P/E 17.5
- Book Value ₹ 241
- Dividend Yield 0.64 %
- ROCE 27.3 %
- ROE 32.2 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 27.78% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.67%
- Company has been maintaining a healthy dividend payout of 18.09%
Cons
- No cons found. Suggest something.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
755 | 838 | 811 | 1,095 | 905 | 849 | 897 | 1,135 | 1,052 | 1,049 | 1,258 | 1,400 | |
594 | 631 | 640 | 746 | 700 | 696 | 672 | 774 | 731 | 752 | 835 | 944 | |
Operating Profit | 160 | 207 | 172 | 349 | 205 | 153 | 225 | 361 | 321 | 296 | 423 | 456 |
OPM % | 21% | 25% | 21% | 32% | 23% | 18% | 25% | 32% | 31% | 28% | 34% | 33% |
Other Income | 0 | 0 | 0 | 2 | 3 | 1 | 3 | 0 | 0 | 121 | 0 | 3 |
Interest | 1 | 1 | 1 | 5 | 5 | 4 | 5 | 7 | 7 | 7 | 6 | 2 |
Depreciation | 26 | 28 | 25 | 26 | 27 | 27 | 32 | 33 | 34 | 36 | 36 | 37 |
Profit before tax | 134 | 179 | 145 | 320 | 177 | 122 | 191 | 322 | 280 | 374 | 382 | 420 |
Tax % | 21% | 19% | 22% | 22% | 22% | 12% | 19% | 17% | 17% | 16% | 16% | 17% |
Net Profit | 105 | 144 | 114 | 251 | 139 | 108 | 155 | 269 | 231 | 314 | 319 | 348 |
EPS in Rs | 5.57 | 7.65 | 6.05 | 13.32 | 7.35 | 5.71 | 8.23 | 14.25 | 12.26 | 16.67 | 16.90 | 17.72 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
1,165 | 1,374 | 1,493 | 1,844 | 2,019 | 3,009 | 2,986 | 2,945 | 3,660 | 4,133 | 4,759 | |
1,009 | 1,166 | 1,249 | 1,485 | 1,611 | 2,026 | 2,353 | 2,313 | 2,782 | 2,931 | 3,262 | |
Operating Profit | 156 | 209 | 244 | 359 | 408 | 983 | 633 | 633 | 879 | 1,201 | 1,497 |
OPM % | 13% | 15% | 16% | 19% | 20% | 33% | 21% | 21% | 24% | 29% | 31% |
Other Income | 4 | 13 | 13 | 4 | 3 | 7 | 3 | 7 | 6 | 126 | 124 |
Interest | 28 | 38 | 24 | 10 | 3 | 4 | 3 | 2 | 15 | 25 | 22 |
Depreciation | 30 | 34 | 35 | 40 | 44 | 72 | 83 | 102 | 106 | 136 | 143 |
Profit before tax | 102 | 150 | 198 | 312 | 363 | 914 | 550 | 535 | 765 | 1,167 | 1,456 |
Tax % | 20% | 20% | 21% | 24% | 21% | 24% | 22% | 21% | 20% | 17% | |
Net Profit | 82 | 121 | 157 | 238 | 287 | 699 | 431 | 422 | 611 | 969 | 1,212 |
EPS in Rs | 6.39 | 8.35 | 12.64 | 15.20 | 37.06 | 22.84 | 22.38 | 32.42 | 51.42 | 63.55 | |
Dividend Payout % | 7% | 22% | 30% | 24% | 23% | 11% | 18% | 18% | 17% | 19% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 11% |
TTM: | 26% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 28% |
3 Years: | 31% |
TTM: | 82% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 26% |
1 Year: | 81% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 30% |
3 Years: | 27% |
Last Year: | 32% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
38 | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 39 | |
Reserves | 239 | 323 | 422 | 592 | 796 | 1,493 | 1,830 | 2,157 | 2,675 | 3,308 | 4,701 |
Borrowings | 328 | 353 | 187 | 109 | 194 | 0 | 8 | 622 | 1,059 | 1,687 | 600 |
238 | 277 | 352 | 423 | 484 | 651 | 634 | 862 | 777 | 846 | 1,096 | |
Total Liabilities | 816 | 991 | 999 | 1,162 | 1,511 | 2,182 | 2,509 | 3,678 | 4,549 | 5,879 | 6,437 |
272 | 268 | 344 | 397 | 489 | 697 | 799 | 918 | 1,085 | 1,276 | 1,260 | |
CWIP | 26 | 58 | 32 | 21 | 83 | 92 | 348 | 741 | 1,107 | 1,570 | 1,825 |
Investments | 3 | 3 | 3 | 33 | 33 | 37 | 103 | 299 | 506 | 833 | 898 |
514 | 661 | 619 | 711 | 906 | 1,355 | 1,259 | 1,720 | 1,850 | 2,199 | 2,454 | |
Total Assets | 816 | 991 | 999 | 1,162 | 1,511 | 2,182 | 2,509 | 3,678 | 4,549 | 5,879 | 6,437 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
105 | 125 | 274 | 263 | 180 | 848 | 327 | 305 | 809 | 540 | |
-57 | -56 | -67 | -111 | -199 | -292 | -511 | -794 | -754 | -822 | |
-47 | -45 | -229 | -151 | 18 | -276 | -96 | 498 | 80 | 166 | |
Net Cash Flow | 1 | 24 | -21 | 1 | -1 | 280 | -280 | 9 | 135 | -116 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 28% | 33% | 47% | 41% | 72% | 32% | 23% | 24% | 27% | |
Debtor Days | 63 | 50 | 57 | 52 | 61 | 45 | 57 | 77 | 54 | 69 |
Inventory Turnover | 2.77 | 2.60 | 2.58 | 2.19 | 1.90 | 1.72 | 1.55 | 1.39 | 1.16 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 12 Jan
- Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Jan
- Shareholding for the Period Ended December 31, 2020 7 Jan
- Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December, 2020 7 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 7 Jan
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2012 from nse
- Financial Year 2011 from bse